{
  "docId": "019de073-e8d5-735f-8ffd-8a5102406a96",
  "docSlug": "3003a94fa3be7c8f2ff0fbac5a54b26e",
  "documentTitle": "Arbutus Biopharma | Results Presentation Deck | 15 slides",
  "authorId": "arbutus-biopharma",
  "authorName": "Arbutus Biopharma",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 15,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "before_after",
  "function": "analyze_data",
  "density": "sparse",
  "nDataPoints": 14,
  "notes": "Data presented at AASLD 2022. Ex vivo FluoroSpot Day 42.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e8d5-735f-8ffd-8a5102406a96/13",
  "deckHref": "/decks/019de073-e8d5-735f-8ffd-8a5102406a96",
  "deckJsonHref": "/decks/019de073-e8d5-735f-8ffd-8a5102406a96.json",
  "deckAnchorHref": "/decks/019de073-e8d5-735f-8ffd-8a5102406a96#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Liver HBV-Specific T Cells (IFN-gamma and IL-2)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fee9d468-c0c1-4f6c-bcd5-d2b073d319a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.5,
        "x": 0.45,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Anti-HBs plasma levels",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00026349-a641-47cf-b30c-bd8fb7424bd1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "AB-101+ siRNA Combination: Increases HBV-Specific T Cell Activity and HBsAb in Liver",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5064cee-edff-400e-b6b7-3a5ea18c2040",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "a3d9c0b8-c8dc-4886-b4bc-fdf1a8921229",
      "evidence": "AB-101+ siRNA combination therapy significantly enhances HBV-specific T cell activity and HBsAb levels compared to monotherapy or vehicle.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}